Medicines Co. (MDCO) Reports Q3 Loss Per Share of $1.19, Less Than Expected

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Medicines Co. (MDCO) Reports Q3 Loss Per Share of $1.19, Less Than Expected

The Medicines Company Reports Third-Quarter 2017 Business and Financial Results

October 25, 2017 7:00 AM EDT

PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ: MDCO) today reported its financial results for the third quarter ended September 30, 2017, and provided an update on its clinical and operational activities.

We made significant clinical and strategic progress during the third quarter, said Clive Meanwell, M.D., Ph.D., Chief Executive Officer of The Medicines Company. We aggressively advanced start-up work for the inclisiran Phase III clinical program, preparing investigational siteswhich began screening patients in Septemberand manufacturing double-blind-packaged drug supply, and are pleased to announce... More